This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Newcomb, P. A. Articles by Egan, K. M. Search for Related Content PubMed PubMed Citation Articles by Newcomb, P. A. Articles by Egan, K. M.

Vitamin D Receptor Polymorphism and Breast Cancer Risk¹

Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 [P. A. N., H. K.]; University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin 53706 [P. A. N., A. T-D.]; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02015 [D. H., K. M. E.]; and Center for Ecogenetics, Department of Environmental Health, University of Washington School of Public Health and Community Medicine, Seattle, Washington 98195 [F. F.]

	Introduction

Top Introduction Materials and Methods Results Discussion References

 
Epidemiological evidence suggests that vitamin D from sunlight and diet may be inversely associated with breast cancer incidence. 1,25(OH)₂D₃, the physiologically active metabolite of vitamin D, exerts growth regulatory functions by binding to the VDR³ (1) . As with many tissues, the breast, both normal and malignant, expresses VDR. The VDR gene is polymorphic at several sites; the BsmI, ApaI, and TaqI polymorphisms are in strong linkage disequilibrium in Caucasians. These common polymorphisms in the gene may alter transcriptional activity and mRNA stability, and may be associated with circulating levels of 1,25(OH)₂D₃ (2) . Several VDR polymorphisms have been associated with breast cancer risk (3, 4, 5, 6) . In our population-based study we investigated the association between the VDR polymorphism TaqI and breast cancer risk.

	Materials and Methods

Top Introduction Materials and Methods Results Discussion References

 
Incident cases of invasive breast cancer in women ages 20–69 years were identified by the Wisconsin statewide cancer registry from January to December 1998 as part of a multicenter population-based case-control study. Five hundred thirty-two cases completed the interview (overall response rate 82%). For comparison, controls were randomly selected from lists of drivers (ages <65 years) and Medicare beneficiary files (ages 65–69 years); 570 control women participated (overall response rate 80%).

All of the women completed a structured 45-min telephone interview covering breast cancer risk factors. Tumor stage information was available from registry files. DNA was collected from mouthwash samples obtained through a mailer (7) . Kits were returned by 79% (n = 420) of the interviewed cases and 71% (n = 405) of the interviewed controls. Determination of TaqI genotype was conducted by the Molecular Biomarkers Laboratory in the Center of Ecogenetics and Environmental Health at the University of Washington, Seattle, WA, using a TaqMan assay.

The association between the TaqI VDR genotype and incidence of breast cancer was evaluated in multivariate logistic regression models. Effect modification between VDR genotype and breast cancer risk was evaluated by testing whether the inclusion of an interaction term in the logistic model significantly changed the log-likelihood.

	Results

Top Introduction Materials and Methods Results Discussion References

 
The control population was in Hardy-Weinberg equilibrium (² = 0.003; P > 0.99). There was no overall association between VDR genotype and breast cancer risk (Table 1) . Relative to the TT genotype, the OR for breast cancer was 1.06 (95% CI, 0.77–1.48) for the Tt genotype, and for the tt genotype the OR was 1.15 (95% CI, 0.72–1.82). The OR for the tt genotype was 0.75 (95% CI, 0.35–1.59) for regional/distant disease, whereas the OR for local disease was 1.31 (95% CI, 0.78–2.18; P interaction = 0.07). There was a suggestion that postmenopausal hormone users with the tt genotype were at decreased risk of breast cancer (OR = 0.35; 95% CI, 0.13–0.93; P interaction = 0.10). The association between VDR genotype and breast cancer risk did not vary by age (P interaction = 0.98; data not shown), menopausal status, family history, multivitamin use (a marker of calcium intake), or body mass index (Table 1) .

	Discussion

Top Introduction Materials and Methods Results Discussion References

Unlike some previous studies, this study was population-based and had available extensive information on known risk factors for breast cancer. Our study had >95% power to detect a doubling of risk associated with the TT genotype. However, we evaluated a single polymorphism, TaqI, although at least three polymorphisms have been described (3) . In addition, the functional significance of the TaqI polymorphism has not yet been ascertained. Finally, because multiple sources of vitamin D may impact on circulating levels of 1,25(OH)₂D₃, our incomplete control of exposure may have limited our assessment.

In summary, we observed no overall association between the VDR TaqI polymorphism and breast cancer risk in our population-based sample; however, this polymorphism may modify the association between postmenopausal hormone use and breast cancer risk.

	Acknowledgments

 
We thank Drs. Meir Stampfer, Walter Willett, Linda Titus Ernstoff, and Barry Storer for valuable advice at various stages of this project; Cassie Keener for laboratory analysis; Linda Haskins for project management; and Mari Nakayoshi and Mary Pankratz for editorial assistance.

	Footnotes

 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ This work was supported by CA47147 and CA71597 from the National Cancer Institute, NIH, Department of Health and Human Services, by Center Grant ES07033 from the National Institute of Environmental Health Sciences, and by institutional funds from the Fred Hutchinson Cancer Research Center.

² To whom requests for reprints should be addressed, at Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, 1100 Fairview, MP-900, Seattle, WA 98109.

³ The abbreviations used are: VDR, vitamin D receptor; OR, odds ratio; CI, confidence interval.

Received 6/19/02; revised 7/29/02; accepted 8/19/02.

	References

Top Introduction Materials and Methods Results Discussion References

 

1. Lipkin M., Newmark H. L. Vitamin D, calcium and prevention of breast cancer: a review. J. Am. Coll. Nutr., 18: 392S-397S, 1999.[Abstract/Free Full Text]
2. Ma J., Hennekens C. H., Hollis B. W., Haddad J. G., Stampfer M. J. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol. Biomark. Prev., 5: 121-126, 1996.[Abstract/Free Full Text]
3. Ingles S. A., Garcia D. G., Wang W., Nieters A., Henderson B. E., Kolonel L. N., Haile R. W., Coetzee G. A. Vitamin D receptor genotype and breast cancer in Latinas (United States). Cancer Causes Control, 11: 25-30, 2000.[Medline]
4. Lundin A. C., Soderkvist P., Eriksson B., Bergman-Jungestrom M., Wingren S. Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group. Cancer Res., 59: 2332-2334, 1999.[Abstract/Free Full Text]
5. Curran J. E., Vaughan T., Lea R. A., Weinstein S. R., Morrison N. A., Griffiths L. R. Association of a vitamin D receptor polymorphism with sporadic breast cancer development. Int. J. Cancer, 83: 723-726, 1999.[Medline]
6. Dunning A. M., McBride S., Gregory J., Durocher F., Foster N. A., Healey C. S., Smith N., Pharoah P. D., Luben R. N., Easton D. F., Ponder B. A. No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis (Lond.), 20: 2131-2135, 1999.[Abstract/Free Full Text]
7. Garcia-Closas M., Egan K. M., Abruzzo J., Newcomb P. A., Titus-Ernstoff L., Franklin T., Bender P. K., Beck J. C., LeMarchand L., Lum A., Alavanja M., Hayes R. B., Rutter J., Buetow K., Brinton L. A., Rothman N. Collection of genomic DNA from adults in epidemiologic studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomark Prev., 10: 687-696, 2001.[Abstract/Free Full Text]

This article has been cited by other articles:

				S. Wedren, C. Magnusson, K. Humphreys, H. Melhus, A. Kindmark, F. Stiger, M. Branting, I. Persson, J. Baron, and E. Weiderpass Associations between Androgen and Vitamin D Receptor Microsatellites and Postmenopausal Breast Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1775 - 1783. [Abstract] [Full Text] [PDF]

				G. E. Mullin and A. Dobs Vitamin D and Its Role in Cancer and Immunity: A Prescription for Sunlight Nutr Clin Pract, June 1, 2007; 22(3): 305 - 322. [Abstract] [Full Text] [PDF]

				Y. Cui and T. E. Rohan Vitamin d, calcium, and breast cancer risk: a review. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1427 - 1437. [Abstract] [Full Text] [PDF]

				W. Y. Chen, E. R. Bertone-Johnson, D. J. Hunter, W. C. Willett, and S. E. Hankinson Associations Between Polymorphisms in the Vitamin D Receptor and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2335 - 2339. [Abstract] [Full Text] [PDF]

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Newcomb, P. A. Articles by Egan, K. M. Search for Related Content PubMed PubMed Citation Articles by Newcomb, P. A. Articles by Egan, K. M.